Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
International Journal of Dermatology|February 10, 2017
Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registriesMartina Kojanova, Jorga Fialova, Petra Cetkovska, et al.
International Journal of Dermatology|June 27, 2025
Prognostic Biomarkers for Anti-PD-1 Monoclonal Antibodies in the First Line Treatment of Advanced MelanomaMarek Pásek, Emanuel Marques, Vojtěch Tretera, et al.
Dermatology and Therapy|March 5, 2021
Real-World Evidence From More Than 1000 Patients Treated With Adalimumab For Moderate-to-Severe Psoriasis in the Czech RepublicMartina Kojanova, Petra Cetkovska, Daniela Strosova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|July 16, 2015
Elevated serum prolactin levels as a marker of inflammatory arthritis in psoriasis vulgarisMarketa Husakova, Jan Lippert, Jiri Stolfa, et al.
Dermatologic Therapy|February 3, 2021
Demographic data, comorbidities, quality of life, and survival probability of biologic therapy associated with sex-specific differences in psoriasis in the Czech RepublicMartina Kojanova, Jorga Fialova, Petra Cetkovska, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|November 7, 2012
Malignant melanoma in the Czech Republic: incidence and mortality according to sex, age and disease stageJana Vranova, Monika Arenbergerova, Petr Arenberger, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|May 14, 2026
Efficacy of radiotherapy in stabilization of oligoprogressive lesions of malignant melanoma treated with immunotherapyMartin Palkovsky, Alzbeta Hlodakova, Jindrich Kopecky, et al.
Central European Journal of Public Health|April 14, 2022
Real-life experience in the effectiveness, impact on quality of life and safety of dupilumab treatment in patients with moderate to severe atopic dermatitis in the Czech RepublicMilena Tánczosová, Martina Kojanová, Monika Arenbergerová, et al.
Dermatology and Therapy|June 5, 2021
Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech RepublicSpyridon Gkalpakiotis, Petra Cetkovska, Petr Arenberger, et al.
Lancet (London, England)|August 16, 2014
Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trialAndrea Vaclavkova, Sergio Chimenti, Petr Arenberger, et al.
Pageof 7